{
    "nctId": "NCT00451022",
    "briefTitle": "Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies",
    "officialTitle": "Follow-Up Study of Subjects Previously Enrolled in Immunotherapy Studies Utilizing Gene Transfer or Other Immunotherapeutic Agents",
    "overallStatus": "RECRUITING",
    "conditions": "Prostate Cancer, Liver Cancer, Breast Cancer, Colon Cancer, Lung Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 750,
    "primaryOutcomeMeasure": "To provide a mechanism for adequate follow-up of subjects previously participating in gene transfer or other immunotherapy studies at the National Cancer Institute as required by the U.S. Food and Drug Administration.",
    "eligibilityCriteria": "* INCLUSION CRITERIA:\n* Subjects who received poxviral vectors (vaccinia and/or fowlpox) or other vaccines utilizing gene transfer or any other immunotherapeutic agent through GMB, UOB and LTIB affiliated trials at the National Cancer Institute, as well as subjects at extramural sites receiving these agents as part of a multi-site trial. Available stored specimens obtained from NCI participants in GMB, UOB, and LTIB affiliated protocols may be transferred to this protocol for storage and eventual future research use.\n* Subjects must be \\>= 18 years of age.\n\nEXCLUSION CRITERIA:\n\nParticipants unwilling to participate.\n\n(Please note, participants may participate in this protocol and, at the same time, participate in an active treatment or continuing care study.)",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}